168 HR ethinyl estradiol 0.00146 MG/HR / norelgestromin 0.00625 MG/HR Transdermal System
RxNorm concept 1534809, clinical drug (scd). Prescribable name: norelgestromin 150 MCG / ethinyl estradiol 35 MCG per Day Weekly Transdermal System.
- RxCUI
- 1534809
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1534809 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
ethinyl estradiol 35 MCG / norelgestromin 150 MCG per 24HR 7 Day Transdermal Patch; norelgestromin 150 MCG / ethinyl estradiol 35 MCG per Day Weekly Transdermal System
Related concepts
- norelgestromin 0.00625 MG/HR (SCDC, consists of)
- ethinyl estradiol 0.00146 MG/HR (SCDC, consists of)
- Transdermal System (DF, has dose form)
- 168 HR ethinyl estradiol 0.00146 MG/HR / norelgestromin 0.00625 MG/HR Transdermal System [Xulane] (SBD, has tradename)
- 168 HR ethinyl estradiol 0.00146 MG/HR / norelgestromin 0.00625 MG/HR Transdermal System [Zafemy] (SBD, has tradename)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1534809 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1534809 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1534809. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.